Imagion to start production of MagSense imaging agent for phase II breast cancer trial
Imagion Biosystems has initiated manufacturing of its MagSense imaging agent for its phase II clinical study on HER2+ breast ...
devdiscourse22 小时
Breakthrough in nanoscience: AI automates complex nanoparticle characterization with ...
The successful integration of AI into nanoparticle analysis has profound implications across multiple scientific and ...